Globus Medical GMED Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's finite-lived intangible assets - expected amortization expense (year one).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's finite-lived intangible assets - expected amortization expense (year one)?
- Globus Medical (GMED) reported finite-lived intangible assets - expected amortization expense (year one) of $116.39M in Q1 2026.
- How has Globus Medical's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
- Globus Medical's finite-lived intangible assets - expected amortization expense (year one) increased by 11.3% year-over-year, from $104.59M to $116.39M.
- What is the long-term trend for Globus Medical's finite-lived intangible assets - expected amortization expense (year one)?
- Over 4 years (2020 to 2024), Globus Medical's finite-lived intangible assets - expected amortization expense (year one) has grown at a 68.8% compound annual growth rate (CAGR), from $12.83M to $104.07M.